Unlock Insights into IBD Research | Specialized Experimental Model Solutions

Reliable in vitro models are essential for understanding intestinal barrier dysfunction and evaluating novel therapeutics for inflammatory bowel disease (IBD). Our Caco-2 Monoculture IBD Model is a robust and widely accepted intestinal epithelial platform designed to investigate barrier integrity, inflammatory responses, and compound efficacy in a controlled and reproducible environment.

This downloadable brochure provides an overview of how the Caco-2 Monoculture IBD Model can be applied to support preclinical IBD research and therapeutic development.

Model Overview

The model utilizes polarized Caco-2 intestinal epithelial cells cultured on transwell inserts to establish a functional intestinal barrier that closely mimics key characteristics of the human intestinal epithelium. Following exposure to inflammatory or chemical stimuli, the model reproduces important features of intestinal barrier dysfunction and inflammatory activation associated with IBD.

Key Model Advantages

The brochure highlights several features that make our Caco-2 Monoculture IBD Model a valuable tool for preclinical research:

• Human-Relevant Epithelial Platform
  Established from human intestinal epithelial cells that form polarized monolayers with functional tight junctions, closely resembling key characteristics of the intestinal barrier.
• Robust and Reproducible System
  A well-characterized and highly standardized model that delivers consistent experimental outcomes across studies.
• High-Throughput Screening Capability
  Supports efficient evaluation of multiple compounds, concentrations, and treatment regimens within a single study.
• Quantitative Assessment of Barrier Function
  Enables precise measurement of epithelial integrity, permeability changes, and treatment-induced barrier restoration.
• Flexible Experimental Design
  Compatible with a wide range of inflammatory stimuli, therapeutic modalities, and study objectives to support diverse IBD research needs.

Readouts and Assays

Our Caco-2 Monoculture IBD Model supports a comprehensive range of analytical endpoints, including:

• Transepithelial Electrical Resistance (TEER) measurements
• Intestinal permeability assessment
• Tight junction protein analysis
• Multiplex cytokine profiling
• Inflammatory biomarker evaluation
• Gene expression analysis by qPCR
• Cell viability and proliferation assays
• Immunofluorescence imaging

Discover how our Caco-2 Monoculture IBD Model can help you evaluate epithelial barrier function, improve candidate selection, and accelerate the development of next-generation therapies for inflammatory bowel disease.

You might be interested in...